Gregory A. Otterson, MD

Gregory A. Otterson, MD, discusses data examining immunotherapy alone versus in combination in non–small cell lung cancer.

Gregory A. Otterson, MD, discusses when to start treatment with immunotherapy in patients with non–small cell lung cancer.

Gregory A. Otterson, MD, discusses targetable biomarkers in non–small cell lung cancer.